DCOY: Decoy Therapeutics Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | Armistice Capital, LLC | 9.99% | SEC |
Institutional ownership (Q2 2026)
4 institutions reported holding $31K of Decoy Therapeutics Inc. on Form 13F (4 the quarter before). 2 opened a new position and 2 sold out. Shares held by institutions: +168%.
| Largest holders | Shares | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4,034 | $29K |
| Tower Research Capital LLC (TRC) | 256 | $2K |
| UBS Group AG | 25 | $180 |
| Caitong International Asset Management Co., Ltd | 2 | $14 |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.